Study findings updated . AI-assisted evidence summary, not individual medical advice or a clinician endorsement.
Key findings
Only 7 of 60 pointsConsumer visits fell 60 percentage points; legal shutdown orders explained about 7
Shutdown orders explained little of 2020's plunge in customer visits.
Customer visits to more than 2.25 million businesses fell by 60 percentage points as the pandemic hit, yet legal shutdown orders explain only about 7 points of that. Similar stores across a county line with different rules both saw huge drops. Traffic fell before orders began and tracked local COVID deaths; voluntary avoidance, seemingly from fear of infection, mattered far more.
Shutdown orders alone moved the economy far less than many assumed. When people fear getting sick they stay home anyway, so recovery depends on people feeling safe, not just on orders being lifted. Observational comparison of phone-tracked store visits, March to mid-May 2020; it counts visits, not spending, and misses online purchases.
Cellphone data from almost 45 million US devices tracked weekly customer visits to over 2.25 million businesses, comparing neighboring counties with different shutdown rules in spring 2020.
From the study: “While overall consumer traffic fell by 60 percentage points, legal restrictions explain only 7 percentage points of this.”
Only 7 of 60 points
Goolsbee A et al. Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. Journal of public economics. 2021.
From the study: “customer visits to more than 2.25 million individual businesses across 110 different industries”
Only 7 of 60 points
Goolsbee A et al. Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. Journal of public economics. 2021.
From the study: “Traffic started dropping before the legal orders were in place; was highly influenced by the number of COVID deaths reported in the county”
Only 7 of 60 points
Goolsbee A et al. Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. Journal of public economics. 2021.
Record 6.5% marginsMedian hospital operating margin, 2020–2021, with COVID relief money (2.8% before)
With federal relief, hospital margins hit an all-time high in the pandemic.
The median hospital operating margin (share of revenue left after costs) hit an all-time high of 6.5% in 2020–2021, up from 2.8% before. Relief money mattered: 16.3% of hospitals fell into new financial distress (losing money and worse off than before), versus 46.3% without counting relief. Hospitals in areas with more Hispanic residents fared worse: 19.1% vs 15.5% in distress.
Despite fears of financial ruin, most hospitals ended up better off than before, partly on public money. Some clearly needed help and others did not, which matters for aiming relief in a future crisis. Observational study of hospital financial reports from 2017 to 2021; it cannot separate relief money's effect from other changes, such as a strong stock market.
A national cohort of 4,423 US short-term and critical access hospitals, comparing each hospital's finances before 2020 with 2020–2021 using RAND hospital data.
From the study: “Median (IQR) operating margins from 2020/2021 were at an all-time high of 6.5% (0.2%-13.3%) compared with pre-2020 operating margins of 2.8% (-2.8% to 9.3%).”
Record 6.5% margins
Gidwani R et al. Changes in US Hospital Financial Performance During the COVID-19 Public Health Emergency. JAMA health forum. 2023.
From the study: “720 (16.3%) of hospitals had PHE financial distress, whereas 2047 (46.3%) had PHE financial distress after excluding COVID-19 relief funding from net operating income.”
Record 6.5% margins
Gidwani R et al. Changes in US Hospital Financial Performance During the COVID-19 Public Health Emergency. JAMA health forum. 2023.
From the study: “adjusted probability of PHE financial distress, 19.1% if having a larger proportion of Hispanic residents in the census tract and 15.5% if not”
Record 6.5% margins
Gidwani R et al. Changes in US Hospital Financial Performance During the COVID-19 Public Health Emergency. JAMA health forum. 2023.
$218 billion in 2023Estimated lost earnings from long COVID among working-age adults in one year
Lost earnings from long COVID reached an estimated $218 billion in 2023.
Nearly one in seven adults, about 35 million people, reported having had long COVID (symptoms lingering long after infection). It was linked to higher risks of recent unemployment and financial hardship, with risks climbing as symptoms grew more limiting. Lost earnings among working-age adults were estimated at $211 billion in 2022 and $218 billion in 2023.
Long COVID is a pocketbook problem as well as a health one: millions of working-age people lose income, and the yearly toll did not shrink from 2022 to 2023. Self-reported, repeated cross-sectional Census survey; it shows links, not cause, and the wage estimate leaves out medical and quality-of-life costs.
Analysis of the US Census Bureau's Household Pulse Survey, over 375,000 adults including nearly 50,000 with long COVID, surveyed in fall 2022 and fall 2023.
From the study: “Nearly one in seven adults (~35 million) and working-aged adults (~30 million) reported having a history of long COVID by late 2022 and late 2023.”
$218 billion in 2023
Kim D. A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States. Communications medicine. 2025.
From the study: “I also find having long COVID is linked to higher risks of recent unemployment, financial hardship, and anxiety and depressive symptomatology, with evidence of dose-response relationships.”
$218 billion in 2023
Kim D. A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States. Communications medicine. 2025.
From the study: “The lost earnings due to long COVID among working-aged adults are estimated to total $211 billion in 2022 and $218 billion in 2023.”
$218 billion in 2023
Kim D. A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States. Communications medicine. 2025.
$3,998 out of pocketAverage out-of-pocket cost for privately insured COVID stays with cost sharing
After insurers dropped COVID waivers, most privately insured stays brought patient bills.
Early in the pandemic, many insurers waived patients' share of COVID hospital bills. For privately insured patients, the share of stays with cost sharing (deductibles, copays) was 2.2% to 8.8% through January 2021, then jumped to 82.1% to 84.4% in February to March 2021. Patients whose stays had cost sharing owed on average $3,998 if privately insured and $1,638 with Medicare Advantage.
Having insurance did not make a COVID hospital stay free: once waivers ended, many insured patients faced bills in the thousands, which could lead some to put off care. Claims from one commercial database, March 2020 to March 2021; the authors note the results may not apply to all private or Medicare Advantage plans.
An analysis of 16,450 COVID-19 hospital stays in a US commercial claims database, covering privately insured and Medicare Advantage patients, March 2020 to March 2021.
From the study: “ranged from 2.2% to 8.8% between March 2020 and January 2021, then increased to 82.1% to 84.4% in February to March 2021”
$3,998 out of pocket
Chua KP et al. Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021. JAMA network open. 2022.
From the study: “The mean out-of-pocket spending for these hospitalizations was $3998 for privately insured patients and $1638 for Medicare Advantage patients.”
$3,998 out of pocket
Chua KP et al. Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021. JAMA network open. 2022.
$21,597 per patientExtra medical spending per long COVID patient vs similar patients without it
Long COVID medical spending spiked around diagnosis, then returned to baseline.
Among 25,229 adults diagnosed with long COVID and 126,089 comparison patients without it, spending rose about 6 months before diagnosis, peaked just before it, and returned to baseline within 6 months. Excess spending totaled $21,597 per patient. Over 3 years, long COVID patients averaged $79,777 in total costs, including $5,158 in cost-sharing (their own share).
Long COVID's medical costs hit hardest around diagnosis, including thousands of dollars in patients' own share, a heavy but concentrated burden for families and insurers. Observational claims study in one state, counting only patients coded with long COVID; it cannot prove the extra spending was caused by long COVID.
Colorado all-payer insurance claims, October 2020 to August 2024, following each patient 1 year before and 2 years after a long COVID diagnosis code, with matched comparisons.
From the study: “Sample: 25,229 LC and 126,089 comparison patients across commercial, Medicare, Medicaid, and dual coverage.”
$21,597 per patient
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
From the study: “Spending rose about 6 months before the index date, peaked just before the index date, and returned to baseline within 6 months; excess spending totaled $21,597 per patient.”
$21,597 per patient
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
From the study: “LC patients averaged $79,777 total expenditures over 3 years and $5,158 in cost-sharing.”
$21,597 per patient
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
$10.19 back per $1Estimated return per $1 spent on New York City vaccination, counting lives saved
New York City's vaccine drive returned an estimated $10 per $1.
A model compared New York City's actual pandemic with a simulated one without vaccines. Every $1 spent on vaccination yielded an estimated $10.19 in savings, counting the value of lives saved. Leaving out the value of lives, savings were still $4.27 per $1. The campaign also averted an estimated $27.96 billion in health care spending.
Vaccination was a health measure that also more than paid for itself in this model, even before putting any dollar value on the lives it saved. Simulation model of one city, December 2020 to January 2022; it did not capture every campaign cost, and results rest on its assumptions.
A computer model calibrated to New York City's COVID-19 cases, hospitalizations and deaths, December 2020 to January 2022, comparing the city with and without vaccination.
From the study: “yielding equivalent savings of $10.19 (95% CrI, $9.39-$10.87) in costs of health outcomes for every $1 spent toward both direct and indirect costs of vaccination in New York City”
$10.19 back per $1
Sah P et al. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA network open. 2022.
From the study: “the ROI without VSL was estimated at 427% (95% CrI, 391%-469%), which was equivalent to savings of $4.27”
$10.19 back per $1
Sah P et al. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA network open. 2022.
From the study: “During the study period, the vaccination campaign averted an estimated $27.96 (95% credible interval [CrI], $26.19-$29.84) billion in health care expenditures”
$10.19 back per $1
Sah P et al. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA network open. 2022.
No rise in medical debtNew medical debt in collections kept its prepandemic downward trend
New medical debt kept falling during the pandemic, even in hard-hit areas.
Credit reports showed new medical debt in collections continued its prepandemic downward trend during the pandemic. Changes in medical debt showed no link to local measures of pandemic severity, such as infection rates or rising unemployment. The authors say any rise may have been offset by fewer elective procedures and new government health policies.
Fears that COVID would bury families in medical bills did not show up as new collections debt, suggesting relief policies and postponed elective care may have cushioned households. Cross-sectional study using one credit bureau's data, 2018 to 2021; debts never reported to credit bureaus are not counted.
A national study of quarterly new medical debt in collections on TransUnion credit reports, compared across US zip codes from 2018 to 2021.
From the study: “Medical and nonmedical debt during the pandemic followed the prepandemic downward trends”
No rise in medical debt
Guttman-Kenney B et al. Trends in Medical Debt During the COVID-19 Pandemic. JAMA health forum. 2022.
From the study: “There was no statistically significant association between the percentage change in medical debt and the measures of pandemic severity.”
No rise in medical debt
Guttman-Kenney B et al. Trends in Medical Debt During the COVID-19 Pandemic. JAMA health forum. 2022.
From the study: “These results are consistent with any increase in medical debt being offset by decreases in elective medical procedures and new health care–related governmental policies.”
No rise in medical debt
Guttman-Kenney B et al. Trends in Medical Debt During the COVID-19 Pandemic. JAMA health forum. 2022.
400 fewer cases a dayConfirmed COVID cases per state per day in states newly given paid sick leave
States where workers newly gained paid sick leave saw fewer COVID cases.
A federal emergency law, the Families First Coronavirus Response Act, gave many workers the option of up to two weeks of paid sick leave. Compared with states where workers already had paid sick leave, states that newly gained it saw around 400 fewer confirmed cases per state per day. The authors estimate about one case prevented daily per 1,300 workers newly covered.
Letting sick workers stay home without losing pay is a public-health tool, not just a workplace perk: newly covered states saw slower spread. Observational state comparison; it adjusted for testing and stay-at-home orders but cannot fully prove the leave law caused the drop.
A difference-in-differences study comparing daily new confirmed COVID-19 cases in US states before and after the emergency sick leave law took effect.
From the study: “states that gained access to paid sick leave through the FFCRA saw around 400 fewer confirmed cases per state per day.”
400 fewer cases a day
Pichler S et al. COVID-19 Emergency Sick Leave Has Helped Flatten The Curve In The United States. Health affairs (Project Hope). 2020.
From the study: “This estimate translates into roughly one prevented case per day per 1,300 workers who had newly gained the option to take up to two weeks of paid sick leave.”
400 fewer cases a day
Pichler S et al. COVID-19 Emergency Sick Leave Has Helped Flatten The Curve In The United States. Health affairs (Project Hope). 2020.
Study-specific findings. Different populations, treatments and follow-up periods can produce different results.
Patient cost-sharing was distinct from total health-care spending
In the Colorado Long COVID cohort, average total health-care expenditures were $79,777 over 3 years, while patient cost-sharing was $5,158.
Compared with similar patients without Long COVID, excess spending was $21,597 per patient over the three-year trajectory. Colorado diagnostic-code-based observational data cannot establish cause.
Spending rose before the recorded Long COVID diagnosis
Health-care spending began rising about 6 months before Long COVID diagnosis and returned to its baseline within 6 months after diagnosis.
This is the Colorado cohort's spending timeline around diagnosis, not a measure of when illness began or when symptoms recovered. Diagnostic coding and observational design limit interpretation.
Study details & original results
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
Healthcare expenditures and patient cost-sharing among patients with long COVID across the three-year study window
$79,777 in average total expenditures and $5,158 in cost-sharing over 3 years
Excess spending among long-COVID patients compared with similar patients without long COVID over the three-year trajectory
Long COVID cohorts had higher health-care costs than controls
Mean annual total health-care costs were higher for adults with Long COVID than contemporary controls in both England and Wales. General-practice consultation use in Long COVID cohorts was higher in Wales than England.
Health-service costs are distinct from personal cost-sharing. The Wales-versus-England relative cost comparison and absolute excess per person-year are separate estimates, not a single patient's bill.
Study details & original results
Dashtban, Ashkan et al.. Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.. Journal of the Royal Society of Medicine. 2026.
Mean annual total healthcare cost for adults with Long COVID versus contemporary controls
Wales: £6681.6 vs £2039.9 (3.27-fold); England: £3378.3 vs £1355.8 (2.49-fold)
GP consultation utilisation among Long COVID cohorts in Wales versus England
26.76 (SD 22.07) vs 14.63 (SD 14.34) consultations per person-year; absolute difference 12.13 visits/year
Cross-national multiplicative difference-in-differences comparison of Long COVID-related costs in Wales versus England
25% greater relative Long COVID-related cost increase in Wales (ratio 1.25) 95% CI: 1.09-1.42
Absolute excess corresponding to the greater relative Long COVID-related cost increase in Wales versus England
Financial hardship gaps were larger with severe activity limitations
27 percentage points higher
In a national US adult study, financial hardship was 27 percentage points higher with Long COVID and severe activity limitations, and 9 percentage points higher with mild limitations, each versus never-infected adults.
These are differences between the reported groups, not an individual's probability of hardship or proof that Long COVID caused it.
Study details & original results
Das, Vivekananda. Trends in Financial Hardship by COVID-19 Infection History, Long COVID Status, and Day-to-Day Activity Limitations: A National Study of US Adults.. Family & community health. 2026.
Financial hardship for adults with long COVID and severe activity limitations compared to never-infected adults
27 percentage points higher
Financial hardship for adults with long COVID and mild activity limitations compared to never-infected adults
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
Browse all 13 recorded findingsSearch the original results, comparisons and study details.
3 of 3 source groupsFindings stay together with their study.
SOURCE 063 findings
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
Timing of the healthcare-spending increase around the long-COVID index date
Added
Increase began about 6 months before diagnosis and spending returned to baseline within 6 months after diagnosisSource [6]
SOURCE 024 findings
Dashtban, Ashkan et al.. Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.. Journal of the Royal Society of Medicine. 2026.
Mean annual total healthcare cost for adults with Long COVID versus contemporary controls
Added
Wales: £6681.6 vs £2039.9 (3.27-fold); England: £3378.3 vs £1355.8 (2.49-fold)Source [2]
GP consultation utilisation among Long COVID cohorts in Wales versus England
Added
26.76 (SD 22.07) vs 14.63 (SD 14.34) consultations per person-year; absolute difference 12.13 visits/yearSource [2]
All 4 findings from this source
Cross-national multiplicative difference-in-differences comparison of Long COVID-related costs in Wales versus England
Added
25% greater relative Long COVID-related cost increase in Wales (ratio 1.25)95% CI: 1.09-1.42Source [2]
Absolute excess corresponding to the greater relative Long COVID-related cost increase in Wales versus England
Added
£2501 excess per person-year95% CI: £1707-£3270Source [2]
SOURCE 016 findings
Das, Vivekananda. Trends in Financial Hardship by COVID-19 Infection History, Long COVID Status, and Day-to-Day Activity Limitations: A National Study of US Adults.. Family & community health. 2026.
Browse the 13 original sourcesThe complete bibliography behind this monitor.
[1]
Das, Vivekananda. Trends in Financial Hardship by COVID-19 Infection History, Long COVID Status, and Day-to-Day Activity Limitations: A National Study of US Adults.. Family & community health. 2026.
Dashtban, Ashkan et al.. Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.. Journal of the Royal Society of Medicine. 2026.
Sahakyan, Yeva et al.. Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study.. Canada communicable disease report = Releve des maladies transmissibles au Canada. 2026.
Yehoshua, Alon et al.. Costs and healthcare resource utilization after COVID-19 hospitalization among US Medicare patients: a retrospective claims analysis.. Journal of medical economics. 2026.
Mugwagwa, Tendai et al.. Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis.. Journal of medical economics. 2026.
DeVoss, Rick et al.. Health Care Expenditures and Cost-Sharing Before and After Long COVID: Three-Year Evidence From a Statewide Multi-Payer Cohort.. Medical care research and review : MCRR. 2026.
Kim D. A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States. Communications medicine. 2025.
Chua KP et al. Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021. JAMA network open. 2022.
Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results. Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed.
Download the findings and bibliography displayed in this page snapshot. Values and confidence intervals remain as reported text; this is not a pooled estimate or a systematic review. Product-label observations and editorial takeaways are excluded.
These findings may omit evidence or contain errors and have not been reviewed by a clinician. A citation or download does not establish source verification. Read the original studies for their methods and limitations.
The October 2026 COVID citation audit found errors in this collection. These downloads may still contain affected findings and bibliography entries. Read the correction record before using them.
“Added” dates record entry into the monitor, not publication or clinical review. A null original acquisition or derivation means its historical record is unknown; a current record or verification has its own observation time. The SHA-256 snapshot identifier binds the downloadable public fields. CSV includes finding rows and bibliography-only source rows; JSON includes both lists. Spreadsheet-sensitive CSV cells begin with an apostrophe for safety; JSON preserves the original text.
For attribution, cite ModernDoc and the page URL, data update date and snapshot identifier in the download. Original studies retain their own rights; this download does not grant a licence to their full text.